This work is licensed under a
Creative Commons Attribution 4.0 International License
Adamyan K.G., Chilingaryan A.L. Comparative effectiveness of ivabradine and verapamil in patients with diastolic cardiac insufficiency due to impaired relaxation of the left ventricle. Rational Pharmacotherapy in cardiology; 2009: 3: 31-35.
Singch B.N. Impact of reduced heart rate. Morbidity in cardiovascular disorders. J. Cardiovasc Pharmacol Ther. 2001; 6: 313-31.
Reil J.C., Bohm M. Beautiful results the slower, the better? Lancet 2008; 372: 779-80.
Fox K., Ford I., Steg P.G., Tendera M, Robertson M., Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (Beautiful): a subgroup analysis of a randomized controlled trial. Lancet 2008; 372: 817-821.
Salpeter S.R., Ormiston T.M., Salpeter E.E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125: 21-3.
Thollon C., Cambarrat C., Vian J., Prost J.F., Peglion J.L., Vilaine J.P. Electrophysiological effects of 16257, a novel sino-atrial node modulator, in rabbit and guinea- pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol 1994; 112: 37-42.
Fomin I.V., Valiculova F. Yu. Antianginal effect of long use of avabradine in patients with ischemic heart disease and diabetes mellitus. Journal Cardiology 2009; 3: 9-5.
Komlev A.D., Volkova A.L., Arutunov V.A. Influence of canals blocker Ifivabrodine on the indexes of external breathing functions in patients with chronic obstructive disease of the lungs in the period of stable course of the disease. Ter. Arch. 2010; 3: 23-7.
Abdurarachmanova G.M., Zulkarneev R.H., Zagudulin N.S. Effect of Ifvabradine and salbutamol combination on heart rate frequency and external breathing function in patients with chronic obstructive disease of the lungs in combination with IHD. Collection of thesis of ХХ congress on respiratory organs disease; 10-11.